Clinical trial reportBloodPublished
Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Blood
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Recurrence; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Bispecific; Antibodies, Monoclonal; Adult; Aged; Aged, 80 and over; Middle Aged; Female
- PubMed ID
- 40983036
- Added to directory
- Source checked